Table of Content

1 Report Overview
1.1 GABA Receptor Agonist Drug Definition
1.2 Market by Type
1.2.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Bamaluzole
1.2.3 Phenibut
1.2.4 Baclofen
1.2.5 Gaboxadol
1.2.6 Klonopin (clonazepam)
1.2.7 Tiagbine
1.3 Market Segment by Application
1.3.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Psychiatric Disorders and Depression
1.3.4 Alzheimer
1.3.5 Epilepsy and Seizure
1.3.6 Anxiety and Sleep Disorders
1.3.7 Obesity and Alcoholism
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global GABA Receptor Agonist Drug Sales
2.1 Global GABA Receptor Agonist Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global GABA Receptor Agonist Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global GABA Receptor Agonist Drug Revenue by Region
2.3.1 Global GABA Receptor Agonist Drug Revenue by Region (2018-2023)
2.3.2 Global GABA Receptor Agonist Drug Revenue by Region (2024-2034)
2.4 Global GABA Receptor Agonist Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global GABA Receptor Agonist Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global GABA Receptor Agonist Drug Sales Quantity by Region
2.6.1 Global GABA Receptor Agonist Drug Sales Quantity by Region (2018-2023)
2.6.2 Global GABA Receptor Agonist Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global GABA Receptor Agonist Drug Sales Quantity by Manufacturers
3.1.1 Global GABA Receptor Agonist Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global GABA Receptor Agonist Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by GABA Receptor Agonist Drug Sales in 2024
3.2 Global GABA Receptor Agonist Drug Revenue by Manufacturers
3.2.1 Global GABA Receptor Agonist Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global GABA Receptor Agonist Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by GABA Receptor Agonist Drug Revenue in 2024
3.3 Global GABA Receptor Agonist Drug Sales Price by Manufacturers
3.4 Global Key Players of GABA Receptor Agonist Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of GABA Receptor Agonist Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of GABA Receptor Agonist Drug, Product Offered and Application
3.8 Global Key Manufacturers of GABA Receptor Agonist Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global GABA Receptor Agonist Drug Sales Quantity by Type
4.1.1 Global GABA Receptor Agonist Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global GABA Receptor Agonist Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global GABA Receptor Agonist Drug Revenue by Type
4.2.1 Global GABA Receptor Agonist Drug Historical Revenue by Type (2018-2023)
4.2.2 Global GABA Receptor Agonist Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
4.3 Global GABA Receptor Agonist Drug Price by Type
4.3.1 Global GABA Receptor Agonist Drug Price by Type (2018-2023)
4.3.2 Global GABA Receptor Agonist Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global GABA Receptor Agonist Drug Sales Quantity by Application
5.1.1 Global GABA Receptor Agonist Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global GABA Receptor Agonist Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global GABA Receptor Agonist Drug Revenue by Application
5.2.1 Global GABA Receptor Agonist Drug Historical Revenue by Application (2018-2023)
5.2.2 Global GABA Receptor Agonist Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
5.3 Global GABA Receptor Agonist Drug Price by Application
5.3.1 Global GABA Receptor Agonist Drug Price by Application (2018-2023)
5.3.2 Global GABA Receptor Agonist Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America GABA Receptor Agonist Drug Sales by Company
6.1.1 North America GABA Receptor Agonist Drug Revenue by Company (2018-2023)
6.1.2 North America GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023)
6.2 North America GABA Receptor Agonist Drug Market Size by Type
6.2.1 North America GABA Receptor Agonist Drug Sales Quantity by Type (2018-2034)
6.2.2 North America GABA Receptor Agonist Drug Revenue by Type (2018-2034)
6.3 North America GABA Receptor Agonist Drug Market Size by Application
6.3.1 North America GABA Receptor Agonist Drug Sales Quantity by Application (2018-2034)
6.3.2 North America GABA Receptor Agonist Drug Revenue by Application (2018-2034)
6.4 North America GABA Receptor Agonist Drug Market Size by Country
6.4.1 North America GABA Receptor Agonist Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America GABA Receptor Agonist Drug Revenue by Country (2018-2034)
6.4.3 North America GABA Receptor Agonist Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe GABA Receptor Agonist Drug Sales by Company
7.1.1 Europe GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe GABA Receptor Agonist Drug Revenue by Company (2018-2023)
7.2 Europe GABA Receptor Agonist Drug Market Size by Type
7.2.1 Europe GABA Receptor Agonist Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe GABA Receptor Agonist Drug Revenue by Type (2018-2034)
7.3 Europe GABA Receptor Agonist Drug Market Size by Application
7.3.1 Europe GABA Receptor Agonist Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe GABA Receptor Agonist Drug Revenue by Application (2018-2034)
7.4 Europe GABA Receptor Agonist Drug Market Size by Country
7.4.1 Europe GABA Receptor Agonist Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe GABA Receptor Agonist Drug Revenue by Country (2018-2034)
7.4.3 Europe GABA Receptor Agonist Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China GABA Receptor Agonist Drug Sales by Company
8.1.1 China GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023)
8.1.2 China GABA Receptor Agonist Drug Revenue by Company (2018-2023)
8.2 China GABA Receptor Agonist Drug Market Size by Type
8.2.1 China GABA Receptor Agonist Drug Sales Quantity by Type (2018-2034)
8.2.2 China GABA Receptor Agonist Drug Revenue by Type (2018-2034)
8.3 China GABA Receptor Agonist Drug Market Size by Application
8.3.1 China GABA Receptor Agonist Drug Sales Quantity by Application (2018-2034)
8.3.2 China GABA Receptor Agonist Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC GABA Receptor Agonist Drug Sales by Company
9.1.1 APAC GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC GABA Receptor Agonist Drug Revenue by Company (2018-2023)
9.2 APAC GABA Receptor Agonist Drug Market Size by Type
9.2.1 APAC GABA Receptor Agonist Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC GABA Receptor Agonist Drug Revenue by Type (2018-2034)
9.3 APAC GABA Receptor Agonist Drug Market Size by Application
9.3.1 APAC GABA Receptor Agonist Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC GABA Receptor Agonist Drug Revenue by Application (2018-2034)
9.4 APAC GABA Receptor Agonist Drug Market Size by Region
9.4.1 APAC GABA Receptor Agonist Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC GABA Receptor Agonist Drug Revenue by Region (2018-2034)
9.4.3 APAC GABA Receptor Agonist Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales by Company
10.1.1 Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America GABA Receptor Agonist Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America GABA Receptor Agonist Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America GABA Receptor Agonist Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Advicenne
11.1.1 Advicenne Company Information
11.1.2 Advicenne Overview
11.1.3 Advicenne GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Advicenne GABA Receptor Agonist Drug Products and Services
11.1.5 Advicenne GABA Receptor Agonist Drug SWOT Analysis
11.1.6 Advicenne Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 AstraZeneca GABA Receptor Agonist Drug Products and Services
11.2.5 AstraZeneca GABA Receptor Agonist Drug SWOT Analysis
11.2.6 AstraZeneca Recent Developments
11.3 Athena Drug Delivery Solutions
11.3.1 Athena Drug Delivery Solutions Company Information
11.3.2 Athena Drug Delivery Solutions Overview
11.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Products and Services
11.3.5 Athena Drug Delivery Solutions GABA Receptor Agonist Drug SWOT Analysis
11.3.6 Athena Drug Delivery Solutions Recent Developments
11.4 Biocodex
11.4.1 Biocodex Company Information
11.4.2 Biocodex Overview
11.4.3 Biocodex GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Biocodex GABA Receptor Agonist Drug Products and Services
11.4.5 Biocodex GABA Receptor Agonist Drug SWOT Analysis
11.4.6 Biocodex Recent Developments
11.5 Elan Corporation
11.5.1 Elan Corporation Company Information
11.5.2 Elan Corporation Overview
11.5.3 Elan Corporation GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Elan Corporation GABA Receptor Agonist Drug Products and Services
11.5.5 Elan Corporation GABA Receptor Agonist Drug SWOT Analysis
11.5.6 Elan Corporation Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Information
11.6.2 Eli Lilly and Company Overview
11.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Products and Services
11.6.5 Eli Lilly and Company GABA Receptor Agonist Drug SWOT Analysis
11.6.6 Eli Lilly and Company Recent Developments
11.7 H.LundBeck, Merck and Co
11.7.1 H.LundBeck, Merck and Co Company Information
11.7.2 H.LundBeck, Merck and Co Overview
11.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Products and Services
11.7.5 H.LundBeck, Merck and Co GABA Receptor Agonist Drug SWOT Analysis
11.7.6 H.LundBeck, Merck and Co Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Products and Services
11.8.5 GlaxoSmithKline GABA Receptor Agonist Drug SWOT Analysis
11.8.6 GlaxoSmithKline Recent Developments
11.9 NovaDel Pharma
11.9.1 NovaDel Pharma Company Information
11.9.2 NovaDel Pharma Overview
11.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 NovaDel Pharma GABA Receptor Agonist Drug Products and Services
11.9.5 NovaDel Pharma GABA Receptor Agonist Drug SWOT Analysis
11.9.6 NovaDel Pharma Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Novartis GABA Receptor Agonist Drug Products and Services
11.10.5 Novartis GABA Receptor Agonist Drug SWOT Analysis
11.10.6 Novartis Recent Developments
11.11 OVATION Pharmaceuticals
11.11.1 OVATION Pharmaceuticals Company Information
11.11.2 OVATION Pharmaceuticals Overview
11.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Products and Services
11.11.5 OVATION Pharmaceuticals Recent Developments
11.12 Osmotica Pharmaceutical
11.12.1 Osmotica Pharmaceutical Company Information
11.12.2 Osmotica Pharmaceutical Overview
11.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Products and Services
11.12.5 Osmotica Pharmaceutical Recent Developments
11.13 Pfizer
11.13.1 Pfizer Company Information
11.13.2 Pfizer Overview
11.13.3 Pfizer GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Pfizer GABA Receptor Agonist Drug Products and Services
11.13.5 Pfizer Recent Developments
11.14 sanofi-aventis
11.14.1 sanofi-aventis Company Information
11.14.2 sanofi-aventis Overview
11.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 sanofi-aventis GABA Receptor Agonist Drug Products and Services
11.14.5 sanofi-aventis Recent Developments
11.15 VIVUS
11.15.1 VIVUS Company Information
11.15.2 VIVUS Overview
11.15.3 VIVUS GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 VIVUS GABA Receptor Agonist Drug Products and Services
11.15.5 VIVUS Recent Developments
11.16 XenoPort
11.16.1 XenoPort Company Information
11.16.2 XenoPort Overview
11.16.3 XenoPort GABA Receptor Agonist Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 XenoPort GABA Receptor Agonist Drug Products and Services
11.16.5 XenoPort Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 GABA Receptor Agonist Drug Value Chain Analysis
12.2 GABA Receptor Agonist Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GABA Receptor Agonist Drug Production Mode & Process
12.4 GABA Receptor Agonist Drug Sales and Marketing
12.4.1 GABA Receptor Agonist Drug Sales Channels
12.4.2 GABA Receptor Agonist Drug Distributors
12.5 GABA Receptor Agonist Drug Customers
13 Market Dynamics
13.1 GABA Receptor Agonist Drug Industry Trends
13.2 GABA Receptor Agonist Drug Market Drivers
13.3 GABA Receptor Agonist Drug Market Challenges
13.4 GABA Receptor Agonist Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Bamaluzole
Table 3. Major Manufacturers of Phenibut
Table 4. Major Manufacturers of Baclofen
Table 5. Major Manufacturers of Gaboxadol
Table 6. Major Manufacturers of Klonopin (clonazepam)
Table 7. Major Manufacturers of Tiagbine
Table 8. Global GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global GABA Receptor Agonist Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global GABA Receptor Agonist Drug Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2018-2023)
Table 12. Global GABA Receptor Agonist Drug Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2024-2034)
Table 14. Global GABA Receptor Agonist Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 15. Global GABA Receptor Agonist Drug Sales by Region (2018-2023) & (K Pcs)
Table 16. Global GABA Receptor Agonist Drug Sales Market Share by Region (2018-2023)
Table 17. Global GABA Receptor Agonist Drug Sales by Region (2024-2034) & (K Pcs)
Table 18. Global GABA Receptor Agonist Drug Sales Market Share by Region (2024-2034)
Table 19. Global GABA Receptor Agonist Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 20. Global GABA Receptor Agonist Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 21. Global GABA Receptor Agonist Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global GABA Receptor Agonist Drug Revenue Share by Manufacturers (2018-2023)
Table 23. Global GABA Receptor Agonist Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 24. Global Key Players of GABA Receptor Agonist Drug, Industry Ranking, 2021 VS 2024
Table 25. Global GABA Receptor Agonist Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA Receptor Agonist Drug as of 2024)
Table 27. Global Key Manufacturers of GABA Receptor Agonist Drug, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of GABA Receptor Agonist Drug, Product Offered and Application
Table 29. Global Key Manufacturers of GABA Receptor Agonist Drug, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global GABA Receptor Agonist Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 32. Global GABA Receptor Agonist Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 33. Global GABA Receptor Agonist Drug Sales Quantity Share by Type (2018-2023)
Table 34. Global GABA Receptor Agonist Drug Sales Quantity Share by Type (2024-2034)
Table 35. Global GABA Receptor Agonist Drug Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global GABA Receptor Agonist Drug Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global GABA Receptor Agonist Drug Revenue Share by Type (2018-2023)
Table 38. Global GABA Receptor Agonist Drug Revenue Share by Type (2024-2034)
Table 39. GABA Receptor Agonist Drug Price by Type (2018-2023) & (USD/Pcs)
Table 40. Global GABA Receptor Agonist Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 41. Global GABA Receptor Agonist Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 42. Global GABA Receptor Agonist Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 43. Global GABA Receptor Agonist Drug Sales Quantity Share by Application (2018-2023)
Table 44. Global GABA Receptor Agonist Drug Sales Quantity Share by Application (2024-2034)
Table 45. Global GABA Receptor Agonist Drug Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global GABA Receptor Agonist Drug Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global GABA Receptor Agonist Drug Revenue Share by Application (2018-2023)
Table 48. Global GABA Receptor Agonist Drug Revenue Share by Application (2024-2034)
Table 49. GABA Receptor Agonist Drug Price by Application (2018-2023) & (USD/Pcs)
Table 50. Global GABA Receptor Agonist Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 51. North America GABA Receptor Agonist Drug Revenue by Company (2018-2023) & (US$ Million)
Table 52. North America GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 53. North America GABA Receptor Agonist Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 54. North America GABA Receptor Agonist Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 55. North America GABA Receptor Agonist Drug Revenue by Type (2018-2023) & (US$ Million)
Table 56. North America GABA Receptor Agonist Drug Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America GABA Receptor Agonist Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 58. North America GABA Receptor Agonist Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 59. North America GABA Receptor Agonist Drug Revenue by Application (2018-2023) & (US$ Million)
Table 60. North America GABA Receptor Agonist Drug Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America GABA Receptor Agonist Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 62. North America GABA Receptor Agonist Drug Revenue by Country (2018-2023) & (US$ Million)
Table 63. North America GABA Receptor Agonist Drug Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America GABA Receptor Agonist Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 65. North America GABA Receptor Agonist Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 66. Europe GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 67. Europe GABA Receptor Agonist Drug Revenue by Company (2018-2023) & (US$ Million)
Table 68. Europe GABA Receptor Agonist Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 69. Europe GABA Receptor Agonist Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 70. Europe GABA Receptor Agonist Drug Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe GABA Receptor Agonist Drug Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe GABA Receptor Agonist Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 73. Europe GABA Receptor Agonist Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 74. Europe GABA Receptor Agonist Drug Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe GABA Receptor Agonist Drug Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe GABA Receptor Agonist Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 77. Europe GABA Receptor Agonist Drug Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe GABA Receptor Agonist Drug Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe GABA Receptor Agonist Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 80. Europe GABA Receptor Agonist Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 81. China GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 82. China GABA Receptor Agonist Drug Revenue by Company (2018-2023) & (US$ Million)
Table 83. China GABA Receptor Agonist Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 84. China GABA Receptor Agonist Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 85. China GABA Receptor Agonist Drug Revenue by Type (2018-2023) & (US$ Million)
Table 86. China GABA Receptor Agonist Drug Revenue by Type (2024-2034) & (US$ Million)
Table 87. China GABA Receptor Agonist Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 88. China GABA Receptor Agonist Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 89. China GABA Receptor Agonist Drug Revenue by Application (2018-2023) & (US$ Million)
Table 90. China GABA Receptor Agonist Drug Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 92. APAC GABA Receptor Agonist Drug Revenue by Company (2018-2023) & (US$ Million)
Table 93. APAC GABA Receptor Agonist Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 94. APAC GABA Receptor Agonist Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 95. APAC GABA Receptor Agonist Drug Revenue by Type (2018-2023) & (US$ Million)
Table 96. APAC GABA Receptor Agonist Drug Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC GABA Receptor Agonist Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 98. APAC GABA Receptor Agonist Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 99. APAC GABA Receptor Agonist Drug Revenue by Application (2018-2023) & (US$ Million)
Table 100. APAC GABA Receptor Agonist Drug Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC GABA Receptor Agonist Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 102. APAC GABA Receptor Agonist Drug Revenue by Region (2018-2023) & (US$ Million)
Table 103. APAC GABA Receptor Agonist Drug Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC GABA Receptor Agonist Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 105. APAC GABA Receptor Agonist Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 106. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Company (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 109. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 110. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Type (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 113. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 114. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Application (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Country (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 120. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 121. Advicenne Company Information
Table 122. Advicenne Description and Overview
Table 123. Advicenne GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 124. Advicenne GABA Receptor Agonist Drug Product and Services
Table 125. Advicenne GABA Receptor Agonist Drug SWOT Analysis
Table 126. Advicenne Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Overview
Table 129. AstraZeneca GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 130. AstraZeneca GABA Receptor Agonist Drug Product and Services
Table 131. AstraZeneca GABA Receptor Agonist Drug SWOT Analysis
Table 132. AstraZeneca Recent Developments
Table 133. Athena Drug Delivery Solutions Company Information
Table 134. Athena Drug Delivery Solutions Description and Overview
Table 135. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 136. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
Table 137. Athena Drug Delivery Solutions GABA Receptor Agonist Drug SWOT Analysis
Table 138. Athena Drug Delivery Solutions Recent Developments
Table 139. Biocodex Company Information
Table 140. Biocodex Description and Overview
Table 141. Biocodex GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Biocodex GABA Receptor Agonist Drug Product and Services
Table 143. Biocodex GABA Receptor Agonist Drug SWOT Analysis
Table 144. Biocodex Recent Developments
Table 145. Elan Corporation Company Information
Table 146. Elan Corporation Description and Overview
Table 147. Elan Corporation GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Elan Corporation GABA Receptor Agonist Drug Product and Services
Table 149. Elan Corporation GABA Receptor Agonist Drug SWOT Analysis
Table 150. Elan Corporation Recent Developments
Table 151. Eli Lilly and Company Company Information
Table 152. Eli Lilly and Company Description and Overview
Table 153. Eli Lilly and Company GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 154. Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
Table 155. Eli Lilly and Company GABA Receptor Agonist Drug SWOT Analysis
Table 156. Eli Lilly and Company Recent Developments
Table 157. H.LundBeck, Merck and Co Company Information
Table 158. H.LundBeck, Merck and Co Description and Overview
Table 159. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 160. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
Table 161. H.LundBeck, Merck and Co GABA Receptor Agonist Drug SWOT Analysis
Table 162. H.LundBeck, Merck and Co Recent Developments
Table 163. GlaxoSmithKline Company Information
Table 164. GlaxoSmithKline Description and Overview
Table 165. GlaxoSmithKline GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 166. GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
Table 167. GlaxoSmithKline GABA Receptor Agonist Drug SWOT Analysis
Table 168. GlaxoSmithKline Recent Developments
Table 169. NovaDel Pharma Company Information
Table 170. NovaDel Pharma Description and Overview
Table 171. NovaDel Pharma GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 172. NovaDel Pharma GABA Receptor Agonist Drug Product and Services
Table 173. NovaDel Pharma GABA Receptor Agonist Drug SWOT Analysis
Table 174. NovaDel Pharma Recent Developments
Table 175. Novartis Company Information
Table 176. Novartis Description and Overview
Table 177. Novartis GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 178. Novartis GABA Receptor Agonist Drug Product and Services
Table 179. Novartis GABA Receptor Agonist Drug SWOT Analysis
Table 180. Novartis Recent Developments
Table 181. OVATION Pharmaceuticals Company Information
Table 182. OVATION Pharmaceuticals Description and Overview
Table 183. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 184. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
Table 185. OVATION Pharmaceuticals Recent Developments
Table 186. Osmotica Pharmaceutical Company Information
Table 187. Osmotica Pharmaceutical Description and Overview
Table 188. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 189. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
Table 190. Osmotica Pharmaceutical Recent Developments
Table 191. Pfizer Company Information
Table 192. Pfizer Description and Overview
Table 193. Pfizer GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 194. Pfizer GABA Receptor Agonist Drug Product and Services
Table 195. Pfizer Recent Developments
Table 196. sanofi-aventis Company Information
Table 197. sanofi-aventis Description and Overview
Table 198. sanofi-aventis GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 199. sanofi-aventis GABA Receptor Agonist Drug Product and Services
Table 200. sanofi-aventis Recent Developments
Table 201. VIVUS Company Information
Table 202. VIVUS Description and Overview
Table 203. VIVUS GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 204. VIVUS GABA Receptor Agonist Drug Product and Services
Table 205. VIVUS Recent Developments
Table 206. XenoPort Company Information
Table 207. XenoPort Description and Overview
Table 208. XenoPort GABA Receptor Agonist Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 209. XenoPort GABA Receptor Agonist Drug Product and Services
Table 210. XenoPort Recent Developments
Table 211. Key Raw Materials Lists
Table 212. Raw Materials Key Suppliers Lists
Table 213. GABA Receptor Agonist Drug Distributors List
Table 214. GABA Receptor Agonist Drug Customers List
Table 215. GABA Receptor Agonist Drug Market Trends
Table 216. GABA Receptor Agonist Drug Market Drivers
Table 217. GABA Receptor Agonist Drug Market Challenges
Table 218. GABA Receptor Agonist Drug Market Restraints
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources
List of Figures
Figure 1. GABA Receptor Agonist Drug Product Picture
Figure 2. Global GABA Receptor Agonist Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global GABA Receptor Agonist Drug Market Share by Type in 2024 & 2034
Figure 4. Bamaluzole Product Picture
Figure 5. Phenibut Product Picture
Figure 6. Baclofen Product Picture
Figure 7. Gaboxadol Product Picture
Figure 8. Klonopin (clonazepam) Product Picture
Figure 9. Tiagbine Product Picture
Figure 10. Global GABA Receptor Agonist Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global GABA Receptor Agonist Drug Market Share by Application in 2024 & 2034
Figure 12. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 13. Psychiatric Disorders and Depression
Figure 14. Alzheimer
Figure 15. Epilepsy and Seizure
Figure 16. Anxiety and Sleep Disorders
Figure 17. Obesity and Alcoholism
Figure 18. GABA Receptor Agonist Drug Report Years Considered
Figure 19. Global GABA Receptor Agonist Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 20. Global GABA Receptor Agonist Drug Revenue 2018-2034 (US$ Million)
Figure 21. Global GABA Receptor Agonist Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 22. Global GABA Receptor Agonist Drug Sales Quantity 2018-2034 (K Pcs)
Figure 23. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Region (2018-2023)
Figure 24. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Region (2024-2034)
Figure 25. North America GABA Receptor Agonist Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. North America GABA Receptor Agonist Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Europe GABA Receptor Agonist Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. Europe GABA Receptor Agonist Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. China GABA Receptor Agonist Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. China GABA Receptor Agonist Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. APAC GABA Receptor Agonist Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 32. APAC GABA Receptor Agonist Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 33. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 34. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 35. The Top 10 and Top 5 Players Market Share by GABA Receptor Agonist Drug Sales Quantity in 2024
Figure 36. The Top 10 and Top 5 Players Market Share by GABA Receptor Agonist Drug Revenue in 2024
Figure 37. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 38. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
Figure 39. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
Figure 40. Global GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
Figure 41. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
Figure 42. North America GABA Receptor Agonist Drug Revenue Market Share by Company in 2024
Figure 43. North America GABA Receptor Agonist Drug Sales Quantity Market Share by Company in 2024
Figure 44. North America GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
Figure 45. North America GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
Figure 46. North America GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
Figure 47. North America GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
Figure 48. North America GABA Receptor Agonist Drug Revenue Share by Country (2018-2034)
Figure 49. North America GABA Receptor Agonist Drug Sales Quantity Share by Country (2018-2034)
Figure 50. U.S. GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 51. Canada GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 52. Europe GABA Receptor Agonist Drug Sales Quantity Market Share by Company in 2024
Figure 53. Europe GABA Receptor Agonist Drug Revenue Market Share by Company in 2024
Figure 54. Europe GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
Figure 55. Europe GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
Figure 56. Europe GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
Figure 57. Europe GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
Figure 58. Europe GABA Receptor Agonist Drug Revenue Share by Country (2018-2034)
Figure 59. Europe GABA Receptor Agonist Drug Sales Quantity Share by Country (2018-2034)
Figure 60. Germany GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 61. France GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 62. U.K. GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 63. Italy GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 64. Russia GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 65. China GABA Receptor Agonist Drug Sales Quantity Market Share by Company in 2024
Figure 66. China GABA Receptor Agonist Drug Revenue Market Share by Company in 2024
Figure 67. China GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
Figure 68. China GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
Figure 69. China GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
Figure 70. China GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
Figure 71. APAC GABA Receptor Agonist Drug Sales Quantity Market Share by Company in 2024
Figure 72. APAC GABA Receptor Agonist Drug Revenue Market Share by Company in 2024
Figure 73. APAC GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
Figure 74. APAC GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
Figure 75. APAC GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
Figure 76. APAC GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
Figure 77. APAC GABA Receptor Agonist Drug Revenue Share by Region (2018-2034)
Figure 78. APAC GABA Receptor Agonist Drug Sales Quantity Share by Region (2018-2034)
Figure 79. Japan GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 80. South Korea GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 81. China Taiwan GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 82. Southeast Asia GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 83. India GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 84. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity Market Share by Company in 2024
Figure 85. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue Market Share by Company in 2024
Figure 86. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue Market Share by Type (2018-2034)
Figure 88. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue Market Share by Application (2018-2034)
Figure 90. Middle East, Africa and Latin America GABA Receptor Agonist Drug Sales Quantity Share by Country (2018-2034)
Figure 91. Middle East, Africa and Latin America GABA Receptor Agonist Drug Revenue Share by Country (2018-2034)
Figure 92. Brazil GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Mexico GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 94. Turkey GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 95. Israel GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 96. GCC Countries GABA Receptor Agonist Drug Revenue (2018-2034) & (US$ Million)
Figure 97. GABA Receptor Agonist Drug Value Chain
Figure 98. GABA Receptor Agonist Drug Production Process
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Distributors Profiles
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed